Richard Leigh

Richard Leigh

University of Calgary

H-index: 52

North America-Canada

About Richard Leigh

Richard Leigh, With an exceptional h-index of 52 and a recent h-index of 32 (since 2020), a distinguished researcher at University of Calgary, specializes in the field of asthma, airway remodeling in asthma, assessment of airway inflammation, COPD, early phase clinical trials in asthma and COPD.

His recent articles reflect a diverse array of research interests and contributions to the field:

Synergy between Interleukin-1β, Interferon-γ, and Glucocorticoids to Induce TLR2 Expression Involves NF-κB, STAT1, and the Glucocorticoid Receptor

Biologic Drugs for Severe Asthma

Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health

Impact of Asthma Medications During Pregnancy on Asthma Exacerbation, Maternal, and Neonatal Outcomes

Sounding the alarmins—The role of alarmin cytokines in asthma

Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study

Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells

Cost analysis of a transition care bundle compared with usual care for COPD patients being discharged from hospital: evaluation of a randomized controlled trial

Richard Leigh Information

University

Position

Professor and Head Division of Respiratory Medicine Department of Medicine and Alberta Health Services

Citations(all)

12120

Citations(since 2020)

5052

Cited By

9283

hIndex(all)

52

hIndex(since 2020)

32

i10Index(all)

115

i10Index(since 2020)

81

Email

University Profile Page

University of Calgary

Google Scholar

View Google Scholar Profile

Richard Leigh Skills & Research Interests

asthma

airway remodeling in asthma

assessment of airway inflammation

COPD

early phase clinical trials in asthma and COPD

Top articles of Richard Leigh

Title

Journal

Author(s)

Publication Date

Synergy between Interleukin-1β, Interferon-γ, and Glucocorticoids to Induce TLR2 Expression Involves NF-κB, STAT1, and the Glucocorticoid Receptor

Molecular Pharmacology

Akanksha Bansal

Cora Kooi

Keerthana Kalyanaraman

Sachman Gill

Andrew Thorne

...

2024/1/1

Biologic Drugs for Severe Asthma

Canadian Journal of Health Technologies

Jason R Randall

Richard Leigh

Ellen T Crumley

Sylvia Aponte-Hao

Ngoc Khanh Vu

...

2024/5/1

Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health

Respirology

Allison Michaud

Richard Leigh

2024/3/28

Impact of Asthma Medications During Pregnancy on Asthma Exacerbation, Maternal, and Neonatal Outcomes

The Journal of Allergy and Clinical Immunology: In Practice

Sangmin Lee

Erin Hetherington

Richard Leigh

Kaylee Ramage

Amy Metcalfe

2024/3/26

Sounding the alarmins—The role of alarmin cytokines in asthma

Gail M Gauvreau

Celine Bergeron

Louis‐Philippe Boulet

Donald W Cockcroft

Andréanne Côté

...

2023/2

Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study

Journal of Otolaryngology-Head & Neck Surgery

Andrew V Thamboo

Melissa Lee

Mohit Bhutani

Charles Chan

Yvonne Chan

...

2023/1

Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells

PLoS One

Andrew Thorne

Akanksha Bansal

Amandah Necker-Brown

Mahmoud M Mostafa

Alex Gao

...

2023/6/8

Cost analysis of a transition care bundle compared with usual care for COPD patients being discharged from hospital: evaluation of a randomized controlled trial

PharmacoEconomics-Open

Charles Yan

Jeff Round

Ilke Akpinar

Chantal E Atwood

Lesly Deuchar

...

2023/5

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

The Lancet Respiratory Medicine

Andrew Menzies-Gow

Michael E Wechsler

Christopher E Brightling

Stephanie Korn

Jonathan Corren

...

2023/5/1

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

European Respiratory Journal

Gail M Gauvreau

Jens M Hohlfeld

J Mark FitzGerald

Louis-Philippe Boulet

Donald W Cockcroft

...

2023/3/1

Effects of traffic-related air pollution on exercise endurance, dyspnea, and cardiorespiratory responses in health and COPD: a randomized, placebo-controlled, crossover trial

Chest

Nafeez Syed

Min Hyung Ryu

Satvir Dhillon

Michele R Schaeffer

Andrew H Ramsook

...

2022/3/1

Aerobic exercise training in older men and women—Cerebrovascular responses to submaximal exercise: Results from the Brain in Motion study

Physiological Reports

Sonja L Lake

Veronica Guadagni

Karen D Kendall

Michaela Chadder

Todd J Anderson

...

2022/2

Inhibition of TGFb-induced Fibroblast to Myofibroblast Transition by Conditioned Medium from Human Rhinovirus-infected Airway Epithelial Cells is Mediated by Prostaglandin E2

Diana Pham

Cora Kooi

David Proud

Richard Leigh

2022/1/21

Optimizing COPD acute care patient outcomes using a standardized transition bundle and care coordinator: a randomized clinical trial

Chest

Chantal E Atwood

Mohit Bhutani

Maria B Ospina

Brian H Rowe

Richard Leigh

...

2022/8/1

Long-term modulation of airway remodelling in severe asthma following bronchial thermoplasty

European Respiratory Journal

Nicholas Jendzjowsky

Austin Laing

Michelle Malig

John Matyas

Elaine de Heuvel

...

2022/1/1

Male pituitary-gonadal axis function in obstructive sleep apnoea syndrome: the effect of continuous positive airway pressure

Endocrine Abstracts

Richard Leigh

Siobha n Hamon

Michael McWeeney

O Aonghus

O Paula

2022/5/7

Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

Journal of Biological Chemistry

Akanksha Bansal

Mahmoud M Mostafa

Cora Kooi

Sarah K Sasse

Aubrey N Michi

...

2022/4/1

Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of inhaled corticosteroid/long-acting β2-adrenoceptor agonist …

Molecular Pharmacology

Mahmoud M Mostafa

Christopher F Rider

N Dulmini Wathugala

Richard Leigh

Mark A Giembycz

...

2021/3/1

The effect of benralizumab on allergen-induced responses in subjects with mild allergic asthma

Journal of Allergy and Clinical Immunology

Gail Gauvreau

Roma Sehmi

J FitzGerald

Richard Leigh

Donald Cockcroft

...

2021/2/1

Efficacy of CSJ117 on allergen-induced asthmatic response in mild atopic asthma patients

Pneumologie

J Hohlfeld

GM Gauvreau

LP Boulet

DW Cockcroft

BE Davis

...

2021/4

See List of Professors in Richard Leigh University(University of Calgary)